Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical Case Report
  • Published:

Palliative parenteral nutrition use in patients with intestinal failure as a consequence of advanced pseudomyxoma peritonei: a case series

Subjects

Abstract

Pseudomyxoma peritonei (PMP) is a rare condition complicated by intra-abdominal spread that can cause multilevel gastrointestinal (GI) obstruction. Parenteral nutrition (PN) use in the context of palliative care and malignancy remains controversial. We describe the use of palliative PN in three patients with progressive PMP causing multilevel GI obstruction and intestinal failure. All patients received >90 days of PN. PN was safe in this cohort of patients. However, patient selection and the timing of intervention are important factors when considering the initiation of PN.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

John A. Kellum, Paola Romagnani, … Hans-Joachim Anders

References

  1. Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA . Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 2008; 34: 196–201.

    Article  CAS  Google Scholar 

  2. Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M ESPEN. ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology. Clin Nutr 2009; 28: 445–454.

    Article  CAS  Google Scholar 

  3. Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D . Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution’s 20-year experience. Cancer 2005; 103: 863–868.

    Article  Google Scholar 

  4. Bozzetti F, Santarpia L, Pironi L, Thul P, Klek S, Gavazzi C et al. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients. Ann Oncol 2014; 25: 487–493.

    Article  CAS  Google Scholar 

  5. Duerksen DR, Ting E, Thomson P, McCurdy K, Linscer J, Larsen-Celhar S et al. Is there a role for TPN in terminally ill patients with bowel obstruction? Nutrition 2004; 20: 760–763.

    Article  Google Scholar 

  6. Chermesh I, Mashiach T, Amit A, Haim N, Papier I, Efergan R et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks? Med Oncol 2011; 28: 83–88.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B R Disney.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Disney, B., Karthikeyakurup, A., Ratcliffe, J. et al. Palliative parenteral nutrition use in patients with intestinal failure as a consequence of advanced pseudomyxoma peritonei: a case series. Eur J Clin Nutr 69, 966–968 (2015). https://doi.org/10.1038/ejcn.2015.97

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2015.97

This article is cited by

Search

Quick links